Cook County Health
Quick facts
Marketed products
- Glipizide and Glargine · Diabetes
Glipizide stimulates insulin secretion from pancreatic beta cells, while glargine provides long-acting basal insulin replacement to lower blood glucose. - Glipizide XL
- Non-medicated patch
- NPH insulin and regular insulin
- Warfarin and Enoxaparin · Cardiovascular
Warfarin inhibits vitamin K-dependent clotting factors while enoxaparin is a low-molecular-weight heparin that enhances antithrombin activity to prevent blood clot formation.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Cook County Health
What are Cook County Health's marketed drugs?
Top marketed products include Glipizide and Glargine, Glipizide XL, Non-medicated patch, NPH insulin and regular insulin, Warfarin and Enoxaparin.
Related
- Glipizide and Glargine · Diabetes
- Glipizide XL
- Non-medicated patch
- NPH insulin and regular insulin
- Warfarin and Enoxaparin · Cardiovascular
- Sector hub: All tracked pharma companies